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Purpose: To examine the effects of elevated glucose on the migration and proliferation of 
vascular endothelial cells in an in vitro wound model and to investigate whether nitric 
oxide (NO) mediates the effects of elevated glucose. 
Methods: Migration was investigated in monolayers of bovine aortic endothelial cells 
wounded by scraping and measuring the distance, the number of cells migrating, and the 
area covered by the migrating cells in the presence of various concentrations of glucose. 
The effects of NO were evaluated by adding to the cultures NG-monomethyl arginine 
(NMMA), an inhibitor of NO synthase, or S-ultrosylated penicillamine, which is a 
slow-release agent of NO. Proliferation was investigated in the presence of various 
concentrations of serum, glucose, or both. 
Results: Elevated glucose levels (16.5 and 27.7 mmol/L)  inhibited endothelial cell 
migration in a dose-dependent manner compared with cells cultured in the presence of 
5.5 mmol /L  glucose. Inhibition of migration was also observed when wounded mono- 
layers cultured in 5.5 mmol /L  glucose were treated with S-nitrosylated penicillamine, 
which generates NO. Inhibition of NO synthase by NMMA prevented the inhibition of 
migration observed in media containing 27.7 mmol /L  glucose. Elevated glucose levels 
did not affect cell proliferation except in the presence of 20% fetal bovine serum. 
Conclusion: An elevated glucose level inhibits endothelial cell migration in an in vitro 
wound model, and the inhibition appears to be mediated by increased levels of NO. 
(J Vasc Surg 1997;26:319-26.) 
The integrity of  the endothelia~ cell lining is es- 
sential to the normal functioning of the vasculature; 
compromised integrity plays a significant role in the 
genesis of  a number of vascular diseases. Disruption 
of  lining integrity can result from retraction of adja- 
cent cells or from cell loss that results from proce- 
dures such as balloon angioplasty, vascular econ- 
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struction, and organ implantation, or from chronic 
hemodynamic abnormalities. 
Critical to repairing any endothelial lining defect 
is the ability of the endothelial cells to migrate and 
proliferate. A number of studies have shown that the 
repair process of an endothelial lining defect is initi- 
ated by cell migration and is followed later by cell 
proliferation. 1,2 Narrow defects, one or two cells in 
width, are repaired by cell migration without prolif- 
eration. 3 Likewise, endothelial cell migration pre- 
cedes proliferation during the repair of  blood vessels 
as well as during neovascularization. 4,5 A number of  
factors, such as heparin, 6 vascular permeability fac- 
tor, 7 fibronectin, s acidic 9 and basic 1°,11 fibroblast 
growth factor, and oxidized low-density lipopro- 
tein 12 have been shown to modulate migration and 
proliferation of endothelial cells. In addition to 
chemical factors, mechanical factors such as pulsatile 
vessel stretching caused by blood pressure 13 or sheer 
stress caused by blood flow 14 can affect migration, 
proliferation, or both. The increased incidence of 
atherosclerosis and vascular diseases in diabetes may 
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have its basis on the altered environment of the 
endothelium, namely, elevated circulating lucose. It 
is now established that glucose reacts pontaneously 
with the amino groups of a wide range of proteins to 
form Schiff bases, which through a number of rear- 
rangements lead to the formation of irreversibly 
bound, chemically reactive groups termed advanced 
glycosylation end products (AGEs). These accumu- 
late on vascular wall collagen and basement mem- 
brane proteins as a function of age and glycemia nd 
may be responsible for or contribute to the macroan- 
giopathy that accompanies diabetes. As with the for- 
marion of AGEs, the degree and duration of hyper- 
glycemia are major determinants of vascular 
complications in diabetes. 
Endothelial cells produce nitric oxide (NO) con- 
stitutively and in response to a variety of stimuli, such 
as fluid sheer stress, is pulsatile vessel stretching, 16
and chemical stimuli such as bradyldnin, calcium 
ionophores, 17interferon %18 and glucocorficoids. ~9
NO is emerging as an important cellular egulator; it
plays important roles in diverse physiologic and patho- 
logic processes, uch as vasodilation, inhibition of plate- 
let aggregation, eurotransmission, modulation of pro- 
tein kinase C, 2° and activation of soluble guanylate 
cyclase. 21 In endothelial cells it has been shown that 
exogenous NO inhibits the production ofendothelin 22 
and the proliferation of endothelial cells. 23 
The present study was designed to test the hy- 
pothesis that glucose can modulate levels of NO, and 
this in turn modifies the response of the endothelium 
to external signals. Here we are specifically focusing 
on the effect of glucose and NO modulators on the 
migratory activity of endothelial cells in response to a 
wound, as well as on the ability of endothelial cells to 
proliferate in response to increased concentrations of 
glucose and NO modulators. 
MATERIALS AND METHODS 
Endothelial cell culture. Bovine aortic endo- 
thelial cells were isolated from aortas of 1- to 2-day- 
old calves within 2 hours of death. Cells were isolated 
by methods described previously. 24 Briefly, the aortas 
were rinsed with sterile medium containing mini- 
mum essential medium (MEM), supplemented with 
10% fetal bovine serum (FBS; Gibco lot no. 
31K8041), 50 btg/ml gentamicin, and 2.5 b~g/ml 
amphotericin B. The two ends of the aorta were 
clamped with hemostats, a blunt needle was inserted 
between one of the hemostats, and the aorta was 
filled with complete medium with a syringe; cells 
were mechanically dislodged by withdrawing and 
injecting the medium into the aorta several times. 
The medium was finally withdrawn and placed in 75 
mm plastic culture flasks and cultured at 37 ° C in a 
humidified atmosphere of 95% air and 5% CO 2. Cell 
were passaged using 0.05% trypsin/0.02% ethyl- 
enediamine tetraa,cetic acid. Cells of passages 3 
through 5 were used in this study. 
In vitro endothelial cell wound model. Endo- 
thelial cells were grown to confluence in 35 mm petri 
dishes. After reaching confluence the cell were trans- 
ferred to medium containing 2.5% FBS. After 16 
hours the cultures were treated with 10 I*g/ml 5-flu- 
orouracil (5-FU) to prevent cell proliferation. Eight 
hours after treatment with 5-FU, 10 x 20 mm 
wounds were made by scraping the cell monolayer 
with a piece of razor blade. 
Effect of  glucose and NO modulators on mi- 
gration. The effect of glucose on migration was 
studied by, culturing wounded cell monolayers in the 
presence of physiologic (5.5 mmol /L  = 100 mg%) 
or elevated (16.5 mmol /L  = 300 mg%, and 27.7 
mmol /L  = 500 mg%) concentrations of D-glucose; 
L-glucose (27.7 mmol/L) ,  which is not metabolized 
by cells, was used as a control. The effect of NO was 
studied by exposing the wounded monolayers to the 
NO donor, freshly prepared S-nitrosylated penicilla- 
mine (100, 200, and 400 t*mol/L) or to the NO 
synthase inhibitor, NG-monomethyl arginine 
(NMMA; 0.15 mmol/L) .  All experiments were per- 
formed in quadruplicate at least two times. Experi- 
ments were terminated after 48 hours by fixing the 
monolayers with 10% trichloroacetic acid and were 
stained with toluidine blue. The fixed cells were pho- 
tographed at 10 × magnification using a Leitz phase- 
contrast microscope. Alternatively, the fixed and 
stained cells were photographed at 10× magnifica- 
tion using a Zeiss phase-contrast microscope, and the 
images were stored on an optical disc using the Me- 
dia Grabber program for a Macintosh computer. The 
images were analyzed for distance migrated and sur- 
face area covered by the migrating cells using Sig- 
mascan. The images were calibrated into standard 
units, and all measurements are expressed as number 
of units. The total number of cells was estimated by 
manually counting cells that appeared in the printed 
image used to determine distance and surface area. 
Effect of  glucose and NO modulators on cell 
proliferation. To examine the effect of glucose on 
proliferation, endothelial cells were plated in 24-well 
plates at an initial density of 6000 cells/well. After 
24 hours, "0" time, cell number was determined and 
the medium was changed to a medium containing 
various concentrations of serum, physiologic D-glu- 
cose (5.5 mmol/L) ,  elevated D-glucose (16.5 and 
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Cel l  Number  
Fig. 1. Linear elationship between cell number and total 
cellular protein in the cultures. 
27.7 mmol/L), or L-glucose (27.7 mmol/L). The 
effect of NO was examined by culturing cells in the 
presence of NMMA, an inhibitor of NO synthase. 
Proliferation was quantitated by estimating the total 
cellular protein using the method of Skehan et al.25 
Cell numbers were calculated from a standard curve 
from an experiment in which the cell number was 
determined using a Coulter counter in six replicate 
cultures and total cellular protein in i2 replicate 
cultures. Fig. 1 shows a linear relationship between 
cell number and total protein. 
Cytochemical analysis. Microfilament-con- 
raining stress fibers were stained with fluorescein- 
labeled phalloidin (Molecular Probes Inc., Junction 
City, Ore.). The cells were rinsed briefly in calcium 
and magnesium-free Dulbecco's phosphate-buffered 
saline solution (PBS; Gibco, Grand Island, N.Y.) 
containing 5 mmol/L ethyleneglycol-bis-(~-amin- 
oethylether)-N,N,N',N'-tetraacetic acid (EGTA) 
and then fixed in 4% (weight/volume) paraformalde- 
hyde in PBS-EGTA for 15 minutes. The cells were 
then immersed in 47.5% ethanol containing 5 
mmol/L EGTA, for 15 minutes at room tempera- 
ture and finally held in PBS-EGTA for 5 minutes 
before staining. The cells were stained with a 1:20 
dilution offluorescein-phalloidin n PBS-EGTA for 5 
minutes at 37 ° C. The cells were then rinsed in sev- 
ern changes of PBS-EGTA and mounted in a 1:1 
mix of glycerol and PBS-EGTA. The stained cells 
were viewed using a Nikon photomicroscope 
equipped with epifluorescent illumination and a filter 
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Fig. 2. Effect of5-FU on endothelial cell proliferation. I  
is evident that 5-FU inhibits proliferation at all concentra- 
tions used. 
suitable for fluorescein. Photomicrographs were 
taken using Neopan ASA 1600 film (Fuji Photofilm 
Co., Tokyo). 
As a control for the specificity of the staining 
reaction, cells were preincubated with an excess of 
unlabeled phalloidin (1:10 in PBS-EGTA) before 
and after incubation with fluorescein-phalloidin. 
RESULTS 
Effect of 5-FU on endothelial cell prolifera- 
tion. To establish the concentration of 5-FU that 
would inhibit proliferation but would not be cyto- 
toxic, endothelial cell cultures were treated with 
5-FU at 10, 50, and 100 txg/ml medium. The results 
(Fig. 2) show that all concentrations of 5-FU inhib- 
ited cell proliferation without any cytotoxic effect for 
the duration of the experiment. Treated and un- 
treated cells were morphologically indistinguishable. 
Effect of glucose on cell migration. In the 
presence of physiologic oncentrations of glucose 
(5.5 retool/L), cells migrated as a sheet of elongated 
cells; a few rounded cells were observed in the de- 
nuded surface ahead of the sheet of migrating cells 
(Fig. 3, A). In the presence of elevated glucose (16.5 
and 27.7 mmol/L) "sheet" migration was markedly 
inhibited; however, a number of rounded cells mi- 
grated into the denuded surface (Fig. 3, B). Morpho- 
logically, ceils in the presence of elevated glucose 
stained only very lightly with toluidine blue. The 
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Fig. 3. Micrographs of the modulation of cell migration 
by glucose and NO. Direction of cell migration is toward 
top O f page. A, In the presence of 5.5 mmol/L glucose, 
endothelial cells migrate as a sheet with few single, 
rounded cells detached from leading edge. B, Increasing 
glucose concentration o 27.7 mmol/L results in marked 
inhibition of migration. Cell sheet is not evident; however, 
some rounded cells have migrated onto denuded area of 
dish. C, Treating cultures in thepresence of 27.7 mmol/L 
glucose with NMMA (0.15 mmol/L), an inhibitor of NO 
synthase, abolishes inhibitory effect of el vated glucose. D, 
NMMA also abolishes inhibitory effects of 16.5 mmol/L 
glucose (not shown); on the other hand, addition of S- 
nitrosylated penicillamine, a NO donor, in the presence of 
5.5 mmol/L glucose results in inhibition of migration. 
Original magnification, × 100. 
inhibitory effect of elevated glucose (16.5 and 27.7 
mmol/L) can be prevented by treating the cultures 
with NMMA (Fig. 3, C), and in the presence of 
normal glucose migration is inhibited by the addition 
ofS-nitrosylatcd penicillamine, a NO donor (Fig. 3, 
D). Morphologically, migrating cells in the presence 
of elevated glucose and treated with NMMA are 
indistinguishable from cells migrating in the pres- 
ence of physiologic glucose (compare Figs. 3, A and 
C). The same results were obtained using human 
umbilical vein endothelial cells. However, cells treated 
with S-nitrosylated penicillamine become much larger 
than untreated cells (compare Figs. 3, A and D). 
Cell cytoskeleton. Endothelial cell cultures in 
medium containing 5.5 mmol/L glucose in the pres- 
ence or absence of NMMA showed no qualitative 
differences in microfilament organization; prominent 
cytoplasmic stress fibers were evident in elongated 
cells (Figs. 4, A and B). Stress fibers in cells cultured 
in medium containing 27.7 mmol/L glucose did not 
extend to the edge of the cell but were condensed in
the perinuclear region (Fig. 4, C). Microfilaments in 
cells cultured in elevated glucose that were treated 
with NMMA were organized into wo distinct mor- 
phologic features: stress fibers extending from the 
perinuclear area to the cell edge and a dense periph- 
eral band (Fig. 4, D). 
Role of NO in the glucose-induced inhibition 
of migration. Increasing the glucose in the culture 
medium from 5.5 to 16.5 and 27.7 mmol/L mark- 
edly decreased endothelial cell migration; the de- 
crease was maximal at 27.7 mmol/L glucose 
whether inhibition was expressed as cell number 
(Fig. 5, A), distance migrated (Fig. 5, B), or surface 
area covered by the migrating cells (Fig. 5, C). The 
inhibitory effect of high glucose is not a result of its 
physical effect (i.e., increased osmolarity) because the 
addition of 27.7 mmol/L L-glucose to the culture 
medium containing 5.5 mmol/L D-glucose has no 
effect on migration. To define the mechanism by 
which glucose inhibits endothelial cell migration, we 
examined whether NO mediates the glucose ffects. 
For this purpose we treated wounded cultures with 
elevated glucose and NMMA, an inhibitor of NO 
synthasc or, alternatively, wounded cultures in nor- 
mal glucose were treated with S-nitrosylated penicil- 
lamine, which slowly releases NO. Addition of 
NMMA (0.15 mmol/L) to wounded cultures in the 
presence of 27.7 mmol/L D-glucose prevented the 
inhibition of migration (Fig. 6, A), whereas addition 
of S-nitrosylated penicillamine inhibited endothelial 
cell migration maximally at 100 v~mol/L (Fig. 6, B). 
Because S-nitrosylated penicillamine induced cell hy- 
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pertrophy, the area and distance migrated was not 
compared with untreated cells. 
Effect o f  glucose and NO modulation on en- 
dothelial cell proliferation. Because glucose and 
NO have profound effects on cell migration, we in- 
vestigated whether they also affect cell proliferation. 
Glucose stimulated cell proliferation in 2% serum, 
had no significant effect in 5% and 10% serum, and 
inhibited cell proliferation in 20% serum (Fig. 7). 
NMMA at a concentration of 0.15 mmol /L  had no 
effect on cell proliferation at any serum or glucose 
concentration. 
DISCUSSION 
The diabetic state is characterized by widespread 
vascular macroangiopathy and microangiopathy. 
These widespread vascular anomalies result in poor 
vascular function, delayed wound healing, and accel- 
erated atherosclerosis. Because in the diabetic state 
the endothelium is exposed to elevated concentra- 
tions of glucose, it s likely that some of the vascular 
abnormalities are the result of glucose toxicity. In 
fact, it is known that the delayed wound healing 
observed in patients with diabetes can be accelerated 
and that the vascular complications can be prevented 
by tight control of glucose. 26 
To investigate the role of glucose in wound re- 
pair, we used an endothelial cell Wound model. Ele- 
vated glucose appears to be a potent inhibitor of 
endothelial cell migration that not only inhibits the 
number and the distance cells migrate, but also the 
characteristic "sheet" migration; the few cells that 
migrate in the presence of elevated glucose are 
round and separated from each other. We also 
observed that cells treated with elevated glucose 
stain only faintly with toluidine blue, suggesting 
that elevated glucose modifies cell membrane com- 
ponents. 
Because the mechanism by which elevated glu- 
cose inhibits migration is not known, we considered 
the possibility that the inhibition of migration could 
be mediated by NO, because NO regulates actin 
polymerization at the inner leaflet of the plasma 
membrane, 27an event necessary for cell migration. 
Our results upport he hypothesis that NO mediates 
inhibition of endothelial cell migration; in fact, the 
addition of NMMA, an inhibitor of NO synthase, to 
the wounded cultures prevents abnormal migration; 
furthermore, the addition to wounded cultures of  a 
NO donor in the presence of normal glucose inhibits 
migration, as if the cells were in the presence of 
elevated glucose. It has been reported that elevated 
glucose does increase NO in porcine pancreatic en- 
dothelial cells in culture but not in aortic porcine 
Fig. 4. Fluorescence micrographs of cells stained for F- 
actin with fluorescein phalloidin 48 hours after wounding. 
In the presence of 5.5 mmol/L glucose (A) elongated 
endothelial cells exhibit prominent cytoplasmic stress fi- 
bers; treatment with NMMA did not alter this appearance 
(B). Cells at wound edge of cultures treated with 27.7 
mmol/L of glucose had no stress fibers, but a condensed 
band of fluorescence was evident in perinuclear r gion (C), 
but when they were treated with NMMA, some stress 
fibers became apparent in cytoplasm and a prominent 
dense band of fluorescence (arrowheads) was evident at cell 
periphery (D). Original magnification, ×400. 
cells? 8 Even though we have not measured NO 
directly, the fact that NMMA corrects the migratory 
defect induced by elevated glucose is a strong indica- 
tion that elevated glucose increases the production of 
NO in endothelial cells under our experimental con- 
ditions. The discrepancy between our results and 
those of Suschek et al. 28 may be a result of a species 
differences or to the different experimental condi- 
tions. It is possible that under conditions that allow 
cells to migrate, NO synthase(s) may be regulated in 
a manner different han NO synthase in an undis- 
turbed cell monolayer. To address this question, 
constitutive and inducible NO synthase must be 
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Fig. 5. Effect of  glucose concentration on endothelial cell migration. Elevated glucose in 
culture medium inhibited cell migration as determined by cell number (A), distance migrated 
(B), or surface area covered (C). Inhibition was maximal at 16.6 mmol /L  glucose and was not 
the result of  any physical effect of  increased glucose, because L-glucose at 27.7 mmol /L  did not 
influence any parameters of  migration. 
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Fig. 6. Regulation of endothelial cell migration by mod- 
ulators of NO. Addition to cultures of NMMA (0.15 
mmol/L) prevented inhibitory effect of elevated glucose 
(A), whereas addition of S-nitrosylated penicillamine in- 
hibited normal migration as evidenced by total number of 
migrating ceils (B). Total surface area and distance mi- 
grated followed the same pattern as total number of cells. 
measured under various experimental conditions. In 
preliminary experiments, we have found that ele- 
vated glucose does increase NO. Glucose at 27.7 
mmol /L  increased basal NO (from 15 nmol /L  to 
35.4 nmol /L  per 100 ~tg protein) as well as the 
bradykinin induced NO (from 29.7 nmol /L  to 91.7 
nmol /L  per 100 ~tg protein). 29 
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Fig. 7. Effect of glucose on endothelial cell proliferation. 
Elevated glucose (27.7 mmol/L) increased cell prolifera- 
tion in the presence of 2% FBS, had no effect at 5 and 10% 
FBS, and inhibited proliferation at 20% FBS. Addition of 
NMMA (0.15 mmol/L) had no effect on cell proliferation. 
*Statistically significant difference; p < 0.05. 
Even though the exact mechanism of the detri- 
mental effects of hyperglycemia are not understood, 
there is a large body of literature that suggests that 
the degree and duration of hyperglycemia is the prin- 
cipal risk factor for the microvascular complications 
of diabetes. 3°,31 A number of hypotheses have been 
advanced, such as the polyol hypothesis, which pos- 
tulates that the accumulation of sorbitol in patients 
with diabetes may be responsible for the vascular 
disease .32 Another hypothesis that has been advanced 
suggests that nonenzymatic glycosylation of proteins 
can cause vascular abnormalities, a3 The markedly di- 
minished staining of endothelial cells with toluidine 
blue that we have observed may be the result of 
nonenzymatic glycosylation of plasma membrane 
proteins. Another hypothesis based on the findings 
that elevated glucose increases the levels of diacyl- 
glycerol and protein kinase C activity in vascular 
cells. 34 It has also been suggested that an imbalance 
in the nicotinamide adenine dinucleotide phos- 
phate/reduced nicotinamide adenine dinucleotide 
phosphate l vels caused by hyperglycemia c n lead to 
vascular dysfunction. 35Because glucose and its me- 
tabolites are used by numerous pathways, it is likely 
that the deleterious effects of hyperglycemia are the 
results of a number of different mechanisms. Our 
studies uggest that one mechanism by which hyper- 
glycemia mediates defective migration of endothelial 
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cells is an increase in NO,  which  in turn  nitrosylates 
and ribosylates actin, z7 prevent ing  it f rom rearrang- 
ing into the central  stress fibers seen dur ing  migra-  
t ion. 36 
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